Comparison

CD292 Polyclonal Antibody

Item no. E-AB-30273-20
Manufacturer Elabscience
Amount 20 uL
Quantity options 120 uL 20 uL 200 uL 60 uL
Category
Type Antibody Polyclonal
Applications WB, ELISA
Specific against Human (Homo sapiens)
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias 10q23del, Activin A receptor type II like kinase 3, Activin receptor like kinase 3, Activin receptor-like kinase 3, ACVRLK 3, ACVRLK3, ALK 3, ALK-3, ALK3, BMP type-1A receptor, BMPR 1A, Bmpr, BMPR-1A, Bmpr1a, BMR1A, Bone morphogenetic protein receptor type IA, Bone morphogenetic protein receptor type IA precursor, Bone morphogenetic protein receptor type-1A, BR 1a, BR1a, CD 292, CD292, CD292 antigen, EC 2.7.11.30, Serine threonine protein kinase receptor R5, Serine threonine protein kinase receptor R5 precursor, Serine/threonine-protein kinase receptor R5, SKR 5, SKR5, zBMPR IA, zBMPRIA
Similar products Bmpr1a, Bmpr, Bone morphogenetic protein receptor type-1A, Activin receptor-like kinase 3, Serine/threonine-protein kinase receptor R5, ACVRLK3, ALK3, 10q23del, CD292, SKR5, ALK-3, BMPR-1A, BMP type-1A receptor, Activin A receptor type II like kinase 3, Activin receptor like kinase 3, ACVRLK 3, ALK 3, BMPR 1A, BMR1A, Bone morphogenetic protein receptor type IA, Bone morphogenetic protein receptor type IA precursor, BR 1a, BR1a, CD 292, CD292 antigen, EC 2.7.11.30, Serine threonine protein kinase receptor R5, Serine threonine protein kinase receptor R5 precursor, SKR 5, zBMPR IA, zBMPRIA
Available
Storage Conditions
Store at -20C. Avoid freeze / thaw cycles.
Calculated Molecular Weight
60kDa
Observed Molecular Weight
60kDa
Research Areas
Cancer, Cardiovascular, Metabolism, Signal Transduction, Stem Cells
Background
The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding.
Concentration
1mg/mL
Buffer
PBS with 0.02% sodium azide, 0.5% BSA and 50% glycerol, pH7.4
Purification Method
Affinity purification
Recommended Dilution
WB 1:500-1:2000, ELISA 1:20000
Immunogen
Synthesized peptide derived from the N-terminal region of human CD292.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 20 uL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close